![SciELO - Brasil - Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil SciELO - Brasil - Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil](https://minio.scielo.br/documentstore/1678-8060/TgcT5pvHfWNHLqC5F5nWyxg/564d4093ac1fb20182ef7cd405d3b64713d6c140.gif)
SciELO - Brasil - Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil Epidemiological aspects of hepatitis C virus infection among renal transplant recipients in Central Brazil
![Core Concepts - Monitoring During and After HCV Treatment - Treatment of Chronic Hepatitis C Infection - Hepatitis C Online Core Concepts - Monitoring During and After HCV Treatment - Treatment of Chronic Hepatitis C Infection - Hepatitis C Online](https://cdn.hepatitisc.uw.edu/doc/371-1/baseline-hbv-parameter-patients-who-developed-hbv-flare-during-hcv-daa-therapy.jpg)
Core Concepts - Monitoring During and After HCV Treatment - Treatment of Chronic Hepatitis C Infection - Hepatitis C Online
![Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management Gupta RK, Sakhuja P, Majumdar K, Ali S, Srivastava S, Sachdeva S, Sharma BC, Puri AS - Indian Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management Gupta RK, Sakhuja P, Majumdar K, Ali S, Srivastava S, Sachdeva S, Sharma BC, Puri AS - Indian](https://www.ijpmonline.org/articles/2018/61/3/images/IndianJPatholMicrobiol_2018_61_3_345_236602_t2.jpg)
Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management Gupta RK, Sakhuja P, Majumdar K, Ali S, Srivastava S, Sachdeva S, Sharma BC, Puri AS - Indian
![BMS-790052 is a First-in-class Potent Hepatitis C Virus (HCV) NS5A Inhibitor for Patients with Chronic HCV Infection: Results from a Proof-of-concept Study BMS-790052 is a First-in-class Potent Hepatitis C Virus (HCV) NS5A Inhibitor for Patients with Chronic HCV Infection: Results from a Proof-of-concept Study](https://www.natap.org/2008/images/110408/dms-1.gif)
BMS-790052 is a First-in-class Potent Hepatitis C Virus (HCV) NS5A Inhibitor for Patients with Chronic HCV Infection: Results from a Proof-of-concept Study
![Table 1 from Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia. | Semantic Scholar Table 1 from Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/43d2606a358fedce9e623eba86fdad82b7c7e668/2-Table1-1.png)
Table 1 from Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia. | Semantic Scholar
Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection | PLOS ONE
![Viruses | Free Full-Text | Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies Viruses | Free Full-Text | Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies](https://pub.mdpi-res.com/viruses/viruses-14-01858/article_deploy/html/images/viruses-14-01858-g001.png?1661333403)